BPG is committed to discovery and dissemination of knowledge
Retrospective Cohort Study
Copyright: ©Author(s) 2026.
World J Psychiatry. Apr 19, 2026; 16(4): 114081
Published online Apr 19, 2026. doi: 10.5498/wjp.v16.i4.114081
Table 3 Medication and appointment adherence by psychological status, n (%)
Adherence measureDepression status
Anxiety status
Present (n = 58)
Absent (n = 72)
P value
Present (n = 49)
Absent (n = 81)
P value
MARS-5 score
mean ± SD17.2 ± 2.821.6 ± 2.9< 0.00117.2 ± 3.121.1 ± 2.8< 0.001
Poor (< 17),34 (58.6)22 (30.6)0.00128 (57.1)28 (34.6)0.011
Moderate (17-22)18 (31.0)25 (34.7)15 (30.6)28 (34.6)
Good (≥ 23)6 (10.3)25 (34.7)6 (12.2)25 (30.9)
Appointment adherence
mean ± SD68.2 ± 19.383.0 ± 14.6< 0.00169.8 ± 19.880.5 ± 16.10.001
< 70%26 (44.8)16 (22.2)0.00624 (49.0)18 (22.2)0.001
70%-89%22 (37.9)28 (38.9)16 (32.7)34 (42.0)
≥ 90%10 (17.2)28 (38.9)9 (18.4)29 (35.8)
Injection interval consistency
CV of intervals38.4 ± 12.628.2 ± 10.3< 0.00136.8 ± 13.230.1 ± 11.40.003
Reasons for non-adherence
Forgetfulness42 (72.4)28 (38.9)< 0.00136 (73.5)34 (42.0)< 0.001
Cost concerns22 (37.9)18 (25.0)0.11119 (38.8)21 (25.9)0.120
Transportation issues18 (31.0)12 (16.7)0.04916 (32.7)14 (17.3)0.042
Fear of injections28 (48.3)14 (19.4)< 0.00131 (63.3)11 (13.6)< 0.001


Write to the Help Desk